SI3380487T1 - Sistemi dodatkov za uporabo pri pegilaciji proteinov - Google Patents
Sistemi dodatkov za uporabo pri pegilaciji proteinovInfo
- Publication number
- SI3380487T1 SI3380487T1 SI201630957T SI201630957T SI3380487T1 SI 3380487 T1 SI3380487 T1 SI 3380487T1 SI 201630957 T SI201630957 T SI 201630957T SI 201630957 T SI201630957 T SI 201630957T SI 3380487 T1 SI3380487 T1 SI 3380487T1
- Authority
- SI
- Slovenia
- Prior art keywords
- additive systems
- protein pegylation
- pegylation
- protein
- additive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/64—Relaxins
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562258644P | 2015-11-23 | 2015-11-23 | |
| EP16816042.2A EP3380487B1 (en) | 2015-11-23 | 2016-11-22 | Additive systems for use in protein pegylation |
| PCT/US2016/063313 WO2017091568A1 (en) | 2015-11-23 | 2016-11-22 | Additive systems for use in protein pegylation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3380487T1 true SI3380487T1 (sl) | 2020-11-30 |
Family
ID=57589163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201630957T SI3380487T1 (sl) | 2015-11-23 | 2016-11-22 | Sistemi dodatkov za uporabo pri pegilaciji proteinov |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US10617765B2 (enExample) |
| EP (2) | EP3789395B1 (enExample) |
| JP (2) | JP6921821B2 (enExample) |
| KR (1) | KR102688003B1 (enExample) |
| CN (2) | CN115819494A (enExample) |
| CY (1) | CY1123699T1 (enExample) |
| DK (1) | DK3380487T3 (enExample) |
| ES (1) | ES2827776T3 (enExample) |
| HR (1) | HRP20201832T1 (enExample) |
| HU (1) | HUE052634T2 (enExample) |
| LT (1) | LT3380487T (enExample) |
| PL (1) | PL3380487T3 (enExample) |
| PT (1) | PT3380487T (enExample) |
| RS (1) | RS61072B1 (enExample) |
| SI (1) | SI3380487T1 (enExample) |
| SM (1) | SMT202000649T1 (enExample) |
| WO (1) | WO2017091568A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3380487T1 (sl) * | 2015-11-23 | 2020-11-30 | Bristol-Myers Squibb Company | Sistemi dodatkov za uporabo pri pegilaciji proteinov |
| JP7441826B2 (ja) * | 2018-09-11 | 2024-03-01 | アンブルックス，インコーポレイテッド | インターロイキン－２ポリペプチド抱合物およびその使用 |
| CN111484551B (zh) * | 2020-03-19 | 2022-02-11 | 北京翼方生物科技有限责任公司 | 一种聚乙二醇修饰的重组人碱性成纤维细胞生长因子 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19535571A1 (de) | 1995-09-14 | 1997-03-20 | Boehringer Mannheim Gmbh | Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten |
| TW518219B (en) | 1996-04-26 | 2003-01-21 | Chugai Pharmaceutical Co Ltd | Erythropoietin solution preparation |
| EP0885613A1 (de) | 1997-06-21 | 1998-12-23 | Roche Diagnostics GmbH | Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin |
| DE19734293A1 (de) | 1997-08-08 | 1999-02-11 | Boehringer Mannheim Gmbh | Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen |
| JP5460958B2 (ja) * | 2004-03-17 | 2014-04-02 | アンチキャンサー インコーポレーテッド | タンパク質ポリエチレングリコール（ｐｅｇ）複合体形成を増大させる方法 |
| EP1885404A2 (en) * | 2005-06-01 | 2008-02-13 | Alza Corporation | Bioconjugation reactions for acylating polyethlene glycol reagents |
| HRP20110404T1 (hr) | 2005-11-08 | 2011-08-31 | Ambrx | Ubrzivači za modifikaciju ne-prirodnih aminokiselina i polipeptida ne-prirodnih aminokiselina |
| KR20140012199A (ko) * | 2007-03-30 | 2014-01-29 | 암브룩스, 인코포레이티드 | 변형된 ｆｇｆ-21 폴리펩티드 및 그 용도 |
| JP6508781B2 (ja) | 2013-01-30 | 2019-05-08 | アベラス バイオサイエンシーズ，インク． | 選択的な送達分子及びその使用方法 |
| US20160082119A1 (en) | 2013-04-22 | 2016-03-24 | Avelas Biosciences, Inc. | Selective drug delivery compositions and methods of use |
| CN107108710B (zh) | 2014-10-24 | 2022-02-15 | 百时美施贵宝公司 | 修饰的fgf-21多肽及其用途 |
| SI3380487T1 (sl) * | 2015-11-23 | 2020-11-30 | Bristol-Myers Squibb Company | Sistemi dodatkov za uporabo pri pegilaciji proteinov |
-
2016
- 2016-11-22 SI SI201630957T patent/SI3380487T1/sl unknown
- 2016-11-22 LT LTEP16816042.2T patent/LT3380487T/lt unknown
- 2016-11-22 WO PCT/US2016/063313 patent/WO2017091568A1/en not_active Ceased
- 2016-11-22 HU HUE16816042A patent/HUE052634T2/hu unknown
- 2016-11-22 JP JP2018526713A patent/JP6921821B2/ja active Active
- 2016-11-22 CN CN202211743414.4A patent/CN115819494A/zh active Pending
- 2016-11-22 DK DK16816042.2T patent/DK3380487T3/da active
- 2016-11-22 PL PL16816042T patent/PL3380487T3/pl unknown
- 2016-11-22 RS RS20201382A patent/RS61072B1/sr unknown
- 2016-11-22 KR KR1020187017508A patent/KR102688003B1/ko active Active
- 2016-11-22 PT PT168160422T patent/PT3380487T/pt unknown
- 2016-11-22 EP EP20189107.4A patent/EP3789395B1/en active Active
- 2016-11-22 CN CN201680067897.7A patent/CN108350025B/zh active Active
- 2016-11-22 ES ES16816042T patent/ES2827776T3/es active Active
- 2016-11-22 SM SM20200649T patent/SMT202000649T1/it unknown
- 2016-11-22 HR HRP20201832TT patent/HRP20201832T1/hr unknown
- 2016-11-22 EP EP16816042.2A patent/EP3380487B1/en active Active
- 2016-11-22 US US15/776,923 patent/US10617765B2/en active Active
-
2020
- 2020-02-21 US US16/797,361 patent/US11213589B2/en active Active
- 2020-11-20 CY CY20201101102T patent/CY1123699T1/el unknown
-
2021
- 2021-07-28 JP JP2021123154A patent/JP7257457B2/ja active Active
- 2021-12-03 US US17/541,636 patent/US20220160883A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP6921821B2 (ja) | 2021-08-18 |
| US20200276319A1 (en) | 2020-09-03 |
| WO2017091568A8 (en) | 2018-01-04 |
| JP2021176890A (ja) | 2021-11-11 |
| CN115819494A (zh) | 2023-03-21 |
| CY1123699T1 (el) | 2022-03-24 |
| JP7257457B2 (ja) | 2023-04-13 |
| SMT202000649T1 (it) | 2021-01-05 |
| PL3380487T3 (pl) | 2020-12-28 |
| US10617765B2 (en) | 2020-04-14 |
| HRP20201832T1 (hr) | 2021-01-08 |
| LT3380487T (lt) | 2020-12-28 |
| PT3380487T (pt) | 2020-10-29 |
| HUE052634T2 (hu) | 2021-05-28 |
| KR20180081610A (ko) | 2018-07-16 |
| US11213589B2 (en) | 2022-01-04 |
| KR102688003B1 (ko) | 2024-07-23 |
| EP3789395B1 (en) | 2025-08-27 |
| RS61072B1 (sr) | 2020-12-31 |
| EP3380487B1 (en) | 2020-09-02 |
| EP3789395A1 (en) | 2021-03-10 |
| DK3380487T3 (da) | 2020-12-07 |
| CN108350025A (zh) | 2018-07-31 |
| JP2019503994A (ja) | 2019-02-14 |
| US20220160883A1 (en) | 2022-05-26 |
| ES2827776T3 (es) | 2021-05-24 |
| WO2017091568A1 (en) | 2017-06-01 |
| CN108350025B (zh) | 2023-02-21 |
| US20190351065A1 (en) | 2019-11-21 |
| EP3380487A1 (en) | 2018-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL256867B (en) | Calibration techniques in haptic systems | |
| IL258437B (en) | Growing systems and methods | |
| EP3376607A4 (en) | DRIVING ADAPTER | |
| EP3271801C0 (en) | ONLINE COLLABORATION SYSTEMS AND PROCESSES | |
| IL248770A0 (en) | A trading system | |
| MA47386A (fr) | Protéines de liaison icos | |
| EP3218837C0 (en) | SYSTEMS AND METHODS FOR SMART SPACES | |
| HUE048644T2 (hu) | Adagoló rendszer | |
| EP3455418A4 (en) | CONNECTION SYSTEMS IN ASSEMBLIES OF WEAR ELEMENTS IN CONTACT WITH THE EARTH | |
| DK3195160T3 (da) | Computerstyret doseringssystem | |
| EP3476772A4 (en) | TRANSPORT SYSTEM | |
| SI3265140T1 (sl) | Dostavni sistemi za dostavo skozi sluznico ali skozi kožo | |
| EP3325526A4 (en) | COATING ADDITIVE | |
| DK3364753T3 (da) | Blandevogn | |
| EP3497802A4 (en) | REFERENCE SIGNALING IN ANTENNA NETWORKS | |
| EP3315831A4 (en) | sliding component | |
| EP3562770A4 (en) | TRANSPORT SYSTEM | |
| EP3445347A4 (en) | IMPROVEMENT OF CHEMOTHERAPY | |
| DK3288391T3 (da) | Fodertilsætningsstof | |
| GB201513063D0 (en) | Inspection of moving parts in rotary systems | |
| EP2986625A4 (en) | MIXED MODE LIGANDS | |
| SI3380487T1 (sl) | Sistemi dodatkov za uporabo pri pegilaciji proteinov | |
| PL3297622T3 (pl) | Kombinacje oksykodonu i n-acyloetanoloaminy palmitoiloetanoloaminy do zmniejszenia skutków ubocznych związanych z opioidami | |
| FI20150214A (fi) | Kuljetin | |
| PL3155422T5 (pl) | Demaskowanie endotoksyn w roztworze |